Skip to main content
Heart logoLink to Heart
. 2006 Apr;92(4):436. doi: 10.1136/hrt.2005.072694

Blue‐grey cutaneous discolouration secondary to amiodarone treatment

S Nikolidakis 1, Z S Kyriakides 1, C Barbatis 1
PMCID: PMC1860870  PMID: 16537754

A 78 year old man was admitted to the cardiology department because of atrial fibrillation with rapid ventricular response. He was an inhabitant of a remote rural area and had been treated with amiodarone for five years, but without medical supervision for a long time.

Physical examination revealed a blue‐grey discolouration of his face. The laboratory tests revealed a 100 fold rise of his serum aminotransferase concentrations (AST 3175 μ/l, ALT 2662 μ/l). The drug regimen was discontinued and long term anticoagulation and digoxin treatment were used. A skin biopsy was performed and fixed in formalin. Paraffin sections were stained with haematoxylin and eosin (H&E) stain, Perl's for haemosiderin, and Masson‐Fontana for melanin pigment. The epidermis was normal but scattered aggregates of macrophages containing ample fine golden brown pigment granules negative for haemosiderin and melanin were seen in the dermis with a tendency for perivascular localisation. Single, granule laden histiocytes were also present and there was no evidence of inflammatory response. After amiodarone discontinuation, serum aminotransferase values returned to near normal within a week's time. The skin discolouration was still evident, but diminished, at six months' follow up.

graphic file with name ht72694.f1.jpg

Left: Hyperpigmentation of the face. Right: Haematoxylin and eosin stain (×200) showing pigment containing histiocytes (arrows) around dermal blood vessels.

Footnotes

There is no conflict of interest related to this manuscript

The study complies with current ethical considerations


Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES